首页> 外文期刊>American Journal of PharmTech Research >Formulation Development and Comparative Pharmacokinetic Evaluation of Felodipine Nanoemulsions in SD Rats
【24h】

Formulation Development and Comparative Pharmacokinetic Evaluation of Felodipine Nanoemulsions in SD Rats

机译:非洛地平纳米乳剂在SD大鼠中的配方开发及药代动力学比较

获取原文
           

摘要

  ABSTRACT The present study involves the formulation and evaluation of o/w nanoemulsions with two simple edible oils in micro-liter quantities, avoiding large quantities of surfactants and co-surfactants. The nanoemulsions were prepared by high energy emulsification technique. The process optimization was based on the particle size, size distribution and entrapment efficiency in relation with the quantity of oil and concentration of surfactant. The percent drug content was determined by HPLC with UV detector. The particle size, polydispersity index (PDI), and zeta potential of nanoemulsions were determined by using particle sizer. Stability studies at 4°C for two months, centrifugation and freeze-thaw cycling were carried out.  Pharmacokinetic studies of nanoemulsion and marketed dosage form were performed in male SD rats and blood plasma samples were analyzed by LC-MS/MS. The particle size, polydispersity index (PDI), and zeta potential of nanoemulsions were found to be in the range of 26.8±0.72 to 154.6±11.4 nm, 0.09±0.01 to 0.28±0.06 and 0.07±0.01 to -28±0.65 mv respectively. Transmission electron microscopy (TEM) and stability studies revealed the physical stability of the nanoemulsions. The percent drug content was found to be in the range of 73.74±3.79 to 101.16±1.35. The oral bio-availability was significantly increased in nanoemulsion compared with the marketed dosage form. These results showed a successful incorporation of felodipine into nanoemulsion with high drug loading efficiency and good stability. Key words: Sesame oil, olive oil, felodipine, sonication, Oral bioavailability.
机译:摘要本研究涉及用两种微升量的简单食用油配制和评估o / w纳米乳液,避免使用大量的表面活性剂和辅助表面活性剂。采用高能乳化技术制备了纳米乳液。工艺优化基于与油量和表面活性剂浓度相关的粒度,粒度分布和截留效率。通过具有UV检测器的HPLC确定药物含量的百分比。纳米乳液的粒度,多分散指数(PDI)和Zeta电位通过使用粒度分析仪确定。在4°C下进行了两个月的稳定性研究,进行了离心和冻融循环。在雄性SD大鼠中进行了纳米乳剂和市售剂型的药代动力学研究,并通过LC-MS / MS分析了血浆样品。纳米乳液的粒径,多分散指数(PDI)和Zeta电位分别在26.8±0.72至154.6±11.4 nm,0.09±0.01至0.28±0.06和0.07±0.01至-28±0.65 mv的范围内。透射电子显微镜(TEM)和稳定性研究揭示了纳米乳液的物理稳定性。发现药物含量百分比在73.74±3.79至101.16±1.35的范围内。与市售剂型相比,纳米乳剂的口服生物利用度显着提高。这些结果表明将非洛地平成功地掺入到纳米乳剂中,具有较高的载药效率和良好的稳定性。关键词:麻油,橄榄油,非洛地平,超声处理,口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号